Livinovea at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Livinovea takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions focus on oligonucleotide CMC and the cost of scaling up. With Axolabs it examines the CMC decisions that drive cost of goods in oligonucleotide scale-up, weighing scientific and commercial levers.

OrganizationTIDES Europe 2026 Attendance
Consulting & services
Swiss consultancy providing business, operational and technical support, including tech transfer and process optimization, to pharma, biotech and CDMOs.
Talk
Tue Nov 3
09:00–12:00
CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken.
with Axolabs
Talk
Thu Nov 5
08:00–08:05
Chairwoman's Remarks: Innovations in Oligonucleotide CMC
Oligonucleotide Chemistry, Manufacturing & Controls

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Livinovea

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction